Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate
NCT03034187 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2023-10-18
Summary
The goal is to gain insight in the development and course of the toxicity after a curative treatment of prostate cancer
Conditions
Sponsors & Collaborators
-
University Medical Center Groningen
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-04-30
- Primary Completion
- 2025-01-31
- Completion
- 2028-01-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Radiation and Androgen Ablation for Prostate Cancer
NCT01517451 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk
NCT03417336 ·Status: RECRUITING ·Phase: NA
-
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
NCT01834001 ·Status: RECRUITING
-
18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer
NCT04487847 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors
NCT02704377 ·Status: COMPLETED ·Phase: NA
-
HRQOL in Prostate Cancer Patients Treated With Radiotherapy
NCT05645237 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
NCT04742361 ·Status: COMPLETED ·Phase: PHASE3
-
Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer
NCT01921803 ·Status: COMPLETED ·Phase: PHASE2
-
Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT)
NCT04638049 ·Status: COMPLETED ·Phase: NA
-
Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate Cancer
NCT02302105 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) Brachytherapy
NCT03553212 ·Status: TERMINATED ·Phase: NA
-
Protons Vs. Photons for High-risk Prostate Cancer
NCT05350475 ·Status: RECRUITING ·Phase: NA
-
Study of Diagnostic Performance of [18F]CTT1057 in BCR
NCT04838613 ·Status: COMPLETED ·Phase: PHASE3
-
Prostate Cancer Survey
NCT03128710 ·Status: COMPLETED
-
Ultra-hypofractionated Radiation in Prostate Cancer
NCT03486821 ·Status: COMPLETED ·Phase: NA
-
Tracer-Guided Surgery for Recurrent Prostate Cancer
NCT05555017 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.
NCT06700057 ·Status: RECRUITING
-
A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer
NCT05361902 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
NCT03585114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Local Treatment With RP for Newly-diagnosed mPCa
NCT02138721 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
NCT02312401 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time
NCT01423474 ·Status: COMPLETED ·Phase: NA
-
Assessing Quality of Life of Patients With Prostate Cancer
NCT00041301 ·Status: COMPLETED
-
uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness
NCT03307460 ·Status: UNKNOWN ·Phase: PHASE2
-
Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate Cancer
NCT02803086 ·Status: ACTIVE_NOT_RECRUITING